Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Second Xiangya Hospital of Central South University
Peking University People's Hospital
Memorial Sloan Kettering Cancer Center
Elicio Therapeutics
JaxBio Ltd